In diabetes it is not what the patient
wants, but what the doctor can command and bully his way into making
the patient do. Now the American Association of Clinical
Endocrinologists (AACE) has developed another way, an algorithm this
time, to force, where possible, patients into submission. Much of
what is shown in the layout of the algorithm is aimed at convincing
the patient to follow their doctor's wishes and desires. How else
will they, the doctors, meet their goals? I wonder how soon this
will be put into effect. The algorithm is available herehttps://www.aace.com/publications/algorithm in PDF format.
Following the Table of Contents, the
first page is – Complications-Centric Model for Care of the
Overweight/Obese Patient. They start the information off with Step 1
- evaluation for complications and staging. This is not a nice way
of saying how we are to be treated. Step 2 is treatment options
where only three options are allowed – lifestyle modification,
medical therapy, and surgical therapy (a must if body mass index is
equal to or greater than 35) They will push medication on top of
medication in the medical therapy and insulin is one of those
mentioned when we exhausted our options with the oral medications.
They leave no doubt that surgical procedures will be sought for BMI's
over the limit.
Step 3 is where they may actually
dismiss us as patients as they state, “If
therapeutic targets for improvements in complications not met,
intensify lifestyle and/or medical and/or surgical treatment
modalities for greater weight loss.”
Apparently, diabetes patients will no longer have a choice
and must be made compliant.
The next page is the Prediabetes Algorithm. In searching the page, they do not allow patients to stay off of medications or start and then wean themselves off medications. The assumption is that prediabetes will progress to diabetes. There is one improvement and that is the use of metformin for those at low risk. Maybe now we will see some action by Medicare and insurance. The counter to this is multiple medications when fasting plasma glucose is greater than 100 mg/dl with two-hour plasma glucose greater than 140 mg/dl.
The next page covers - Goals for
Glycemic Control. They leave no doubt about where they are coming
from and what they will be setting for their patients. If you are a
compliant healthy patient without concurrent illness and at low
hypoglycemic risk, you will be allowed to have an A1c of 6.5% or
lower. If on the other side (greater than 6.5%), they will
individualize goals for patients with concurrent illness and at risk
for hypoglycemia.
On the next page, we come to what
should make anyone with diabetes nervous. The page is titled
Glycemic Control Algorithm. It is further subtitled Lifestyle
Modification (Including Medically Assisted Weight Loss). So not to
forget, they are supposedly talking about a couple of the weight loss
medications approved by the FDA. Still in my mind, this should be
classified as medication weight loss therapy and not medically
assisted weight loss. This sounds more like surgery than medication
therapy.
There are three entry A1c listings - 1)
A1c that is less than 7.5%, 2) A1c that is equal to or greater
than 7.5%, and 3) A1c greater than 9.0%. 1) above starts out
as Monotherapy. Metformin is listed first, but they also list
several others and even some that should be used with caution because
of studies lately that show problems affecting the heart and other
side effects. The bottom should raise alarm bells as you are only
given three (only three) months to show improvement, or you will be
moved to Dual therapy. Here basal (long acting insulin) may be part
of the therapy, but this is supposed to be done with caution.
If you don't show improvement in dual
therapy by the end of three months, you are to be moved to Triple
therapy. This means three oral medications and with the order of
suggested usage, they are going with oral medications that should be
used with caution or basal insulin. If you don't succeed in three
months here, you are to be moved to insulin therapy and oral
medications.
Now look at 2) above. Here you will
start on Dual therapy and if no improvement in three months, you
move to Triple therapy. If you don't succeed on triple therapy in
three months, insulin therapy is up next. If you started at 3)
above, then if you have no symptoms (probably meaning no
complications or concurrent illness) you may start at Dual therapy if
your A1c is under 8.0%, otherwise you may start at Triple therapy and
this is when basal insulin is recommended in Dual or Triple therapy.
Now if you have symptoms, then you are to start on basal insulin and
other oral medications as necessary.
The page following this is –
Algorithm for Adding/Intensifying Insulin. The left side of the page
is for basal (long-acting insulin) and not using sulfonylureas but
other oral medications. I will not get into the titration part.
That is between you and your doctor. On the right side is more
intensifying of oral medications and adding prandial (mealtime)
insulin (or short- or rapid- acting insulin).
The last three pages discuss
cardiovascular disease (CVD) risk factor modifications algorithm,
profiles of antidiabetes medications. I was surprised that for the
most part, the page is right on. For comparison on most, use the
different inserts here for each medication. The cardiovascular page
discusses statins and blood pressure lowing medications.
The last page summarizes the guiding
principles for the algorithms. I some ways this is difficult to
swallow as it explains the importance of a lifestyle modification,
the individualization of treatments, and their targets. The
minimization of weight gain and hypoglycemia are worthy discussions.
I summary, I am surprised at what is
not included. This would be exercise (covered in a blog by Tom Ross)
and allowing patients to start without medications or using
medications for bringing prediabetes and diabetes under excellent
management and then weaning off medications as lifestyle goals are
met. No mention is made of working at the prediabetes level of
lifestyle changes to prevent the onset of type 2 diabetes. Also missing is the option for those patients wanting off oral medications and onto the full insulin therapy. Apparently this is not allowed under the algorithm. For these
reasons, I feel strongly that the algorithm is shortsighted and
presents a defeatist attitude.
As a patient, I am very concerned about
how they feel that diabetes is progressive and they offer no hope of
people preventing this. One article about the algorithm may be read
here and another here.
No comments:
Post a Comment